Concepedia

No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: Impact of resistant minority variants on efficacy of low genetic barrier drugs

Kristel Van Laethem, Paul De Munter, Yoeri Schrooten, René Verbesselt, Marc Van Ranst, Eric Van Wijngaerden, Anne‐Mieke Vandamme

Journal of Clinical Virology · 2007 · 42 citations · 18 references

DOI

Concepts

References

18

Treatment for Adult HIV Infection

Scott M. Hammer, Michael S. Saag, Mauro Schechter et al. · JAMA · 2006 · 1K citations

, , +15

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

Joel E. Gallant, Edwin DeJesus, José Ramón Arribas et al. · New England Journal of Medicine · 2006 · 886 citations

, , +12

Treatment for Adult HIV Infection

Patrick Yéni, Scott M. Hammer, Martin Hirsch et al. · JAMA · 2004 · 737 citations

, , +15

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing, David van de Vijver, Gioacchino Angarano et al. · The Journal of Infectious Diseases · 2005 · 420 citations · Full text

, , +17

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

Bluma Brenner, Dan Turner, Maureen Oliveira et al. · AIDS · 2003 · 318 citations

, , +17